Goldman Sachs downgraded Team Health (NYSE: TMH) from Conviction Buy to Buy with a price target of $59.00 (from $56.00).Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE